HQL offers a 14.2% dividend yield and diverse exposure to healthcare and life science companies. Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price ...
HQL fund: 11.6% yield at 9.6% NAV discount. Learn risks of gain-funded payouts, biotech concentration & tax impact—see if it fits your income plan.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results